A Label-free Extracellular-vesicle Automated Purification System (LEAP System)

无标记细胞外囊泡自动纯化系统(LEAP系统)

基本信息

  • 批准号:
    10324624
  • 负责人:
  • 金额:
    $ 19.75万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-01 至 2022-02-28
  • 项目状态:
    已结题

项目摘要

PROJECT SUMMARY / ABSTRACT Extracellular vesicles (EVs) are small lipid bilayer particles secreted by most cell types, which encapsulates biomolecules including lipids, proteins, and nucleic acids from parent cells. Profiling of EV-derived biomarkers provides a promising approach for early diagnoses and prognosis of various diseases. Currently, one of the primary hindrances to the implementation and usage of EVs is lack of a robust method for convenient and high- speed isolation of EVs with high yield and purity. A number of recent publications mentioned that developing efficient and reliable isolation methods is urgent to further advance in this field. There is a strong desire to explore innovated technologies for better performance of EV isolation in terms of throughput, purity, yield, speed, robustness, and cost. To overcome these challenges, WellSIM Biomedical Technologies proposes to develop, optimize, and validate a Label-free Extracellular-vesicle Automated Purification System (LEAP System) for EV isolation from bodily fluids (e.g., plasma and urine) with excellent performance. Based on our current prototype which has shown competitive EV yield, purity, and isolation efficiency, we will further improve the processing speed, sample volume load, and throughput by redesigning and optimizing the System. Our preliminary studies support that, with the proposed improvement, we can expect to simultaneously isolate EVs from up to 6 plasma samples (>2 mL) within 1 hr with purity and yield outperform other EV isolation methods. After system upgrade and optimization, we will comprehensively validate our next-generation platform with cell culture medium, urine, and plasma in terms of yield, purity, speed, and processing volume. Our new platform will directly address the current bottlenecks, and thus provide an advanced EV purification tool for EV-based life science and precision medicine.
项目摘要/摘要 细胞外小泡(EVS)是一种由大多数细胞类型分泌的小的脂质双层颗粒,它包裹着 生物分子,包括来自亲本细胞的脂类、蛋白质和核酸。肠道病毒衍生生物标志物的特征分析 为各种疾病的早期诊断和预后提供了一种很有前途的方法。目前,其中一家 阻碍电动汽车实施和使用的主要障碍是缺乏一种方便和高效的可靠方法。 快速分离出产量高、纯度高的电动汽车。最近的一些出版物提到了发展中的 高效、可靠的分离方法是该领域进一步发展的迫切需要。有一种强烈的探索欲望 在产量、纯度、产量、速度、 健壮性和成本。为了克服这些挑战,WellSIM Biomedical Technologies计划开发, 优化和验证电动汽车的无标签胞外囊泡自动净化系统(LEAP系统) 与体液(如血浆和尿液)隔离,性能优异。基于我们目前的原型 已经显示出具有竞争力的电动汽车产量、纯度和分离效率,我们将进一步改进加工 通过重新设计和优化系统来提高速度、样本量负载和吞吐量。我们的初步研究 支持,通过提议的改进,我们有望同时从多达6个血浆中分离出电动汽车 样品(>2毫升)在1小时内纯度和产量均优于其他EV分离方法。系统升级后 和优化,我们将全面验证我们的下一代平台的细胞培养液,尿液, 和等离子体在产量、纯度、速度和加工量方面。我们的新平台将直接解决 目前的瓶颈,从而为基于电动汽车的生命科学和精确化提供了先进的电动汽车净化工具 医药。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Yuchao Chen其他文献

Yuchao Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Yuchao Chen', 18)}}的其他基金

EXODOTS for diagnostic evaluation and monitoring of Alzheimer's disease
EXODOTS 用于阿尔茨海默病的诊断评估和监测
  • 批准号:
    10600890
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Link phenotypic characteristics with gene expression profile of single cells at high throughput for drug discovery and cell therapy development
以高通量将表型特征与单细胞基因表达谱联系起来,用于药物发现和细胞疗法开发
  • 批准号:
    10482180
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization
对单个外泌体进行多组学分析,以进行起源追踪、生物标志物发现和生物功能表征
  • 批准号:
    10572470
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
Multi-omics profiling of individual exosomes for their origin-tracing, biomarker discovery, and biological function characterization
对单个外泌体进行多组学分析,以进行起源追踪、生物标志物发现和生物功能表征
  • 批准号:
    10384216
  • 财政年份:
    2022
  • 资助金额:
    $ 19.75万
  • 项目类别:
A Label-free Extracellular-vesicle Automated Purification System (LEAP System)
无标记细胞外囊泡自动纯化系统(LEAP系统)
  • 批准号:
    10546042
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
A Label-free Extracellular-vesicle Automated Purification System (LEAP System)
无标记细胞外囊泡自动纯化系统(LEAP系统)
  • 批准号:
    10647831
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease
EXODUS 支持的细胞外囊泡高通量多组学分析用于临床前阿尔茨海默病的诊断
  • 批准号:
    10604194
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:
EXODUS-enabled High-throughput Multi-omics Profiling of Extracellular Vesicles for Diagnosis of Preclinical Alzheimer's Disease
EXODUS 支持的细胞外囊泡高通量多组学分析用于临床前阿尔茨海默病的诊断
  • 批准号:
    10383586
  • 财政年份:
    2021
  • 资助金额:
    $ 19.75万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 19.75万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了